Patent details
300841
Product Name:
Ixekizumab
The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
Ok
Cancel
You have not selected any documents
Ok
Basic Information
Publication number:
300841
Type:
Certificate
SPC Type:
Medical
Basic Patent Number:
EP1641822
Status:
Withdrawn
Application number:
300841
Procedural language:
Dutch
First Applicant Residence Country:
United States of America (US)
Marketing Authorization
Marketing Authorization Number:
EU/1/15/1085
Marketing Authorization Type:
EEA
Marketing Authorization Date:
28/04/2016
Marketing Authorization Country:
European Union (EU)
Dates
Filing date:
24/10/2016
First Marketing Authorization date:
28/04/2016
Grant date:
Activation date:
Lapsed By Non Payment Annual Fee Date:
Renunciation Date:
NullificationDate:
Registration date:
26/10/2016
SPC/SPC Extension Expiration Date:
Lapsed By Expiration Date:
Withdrawal date:
20/04/2020
Revocation Date:
Invalidity Date:
Withdrawal Market Authorization Date:
Refusal Date:
Applicant/holder
From:
26/10/2016
Name:
Genentech, Inc.
Address:
1 DNA Way, SOUTH SAN FRANCISCO, CA 94080-4990, United States of America (US)
Agent
Name:
ir. H.A. Witmans c.s.
From:
26/10/2016
Address:
V.O.
Postbus 87930, 2508 DH, Den Haag, Netherlands (NL)
To:
Publication
Bulletin
1
Bulletin Heading:
VRV
Journal edition number:
31/20
Publication date:
31/07/2020
Description:
Contains data concerning lapse or annulment
2
Bulletin Heading:
VRV
Journal edition number:
17/20
Publication date:
22/04/2020
Description:
Contains data concerning lapse or annulment
3
Bulletin Heading:
SPC
Journal edition number:
43/16
Publication date:
28/10/2016
Description:
Contains data concerning applications for- or granted Supplementary Protection Certificates
Filing date
Document type
Document Description
Number of pages
21/04/2020
Outgoing Correspondence
Letter confirmation withdrawal
1
/5/0/4/1/0/0800101405/docs/300841_5_340062l193.pdf
21/02/2019
Incoming Correspondence Paper
Accompanying letter incoming document
2
/5/0/4/1/0/0800101405/docs/300841_6_incomingcorrespondencepaper20190225085129055.pdf
28/10/2016
Outgoing Correspondence
Confirmation receipt request
1
/5/0/4/1/0/0800101405/docs/300841_1_93978l174.pdf
25/10/2016
Application Form
First filed application form
3
/5/0/4/1/0/0800101405/docs/300841_0_applicationform20161026043851320.pdf
25/10/2016
SPC Documents
Summary of the characteristics of the product
65
/5/0/4/1/0/0800101405/docs/300841_2_supplprotectioncertificate20161026043851653.pdf
25/10/2016
SPC Documents
Marketing Authorization SPC
3
/5/0/4/1/0/0800101405/docs/300841_3_supplprotectioncertificate20161026043851578.pdf
25/10/2016
SPC Documents
Accompanying letter SPC
1
/5/0/4/1/0/0800101405/docs/300841_4_supplprotectioncertificate20210406020832500.pdf